Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis DeSantis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|December 17, 2020
Bruxism: Best Evidence Consensus StatementGary Goldstein, Louis DeSantis, Charles Goodacre
Drugs of Today (Barcelona, Spain : 1998)|April 2, 2003
Travoprost: a potent ocular hypotensive agentAdel M Al-Jazzaf, Louis DeSantis, Peter A Netland
Investigative Ophthalmology & Visual Science|December 31, 2005
Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administrationGábor Holló, Jess T Whitson, Robert Faulkner, et al.
Survey of Ophthalmology|September 3, 2002
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonistMark R Hellberg, Marsha A McLaughlin, Naj A Sharif, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|December 17, 2020
Bruxism: Best Evidence Consensus StatementGary Goldstein, Louis DeSantis, Charles Goodacre
Drugs of Today (Barcelona, Spain : 1998)|April 2, 2003
Travoprost: a potent ocular hypotensive agentAdel M Al-Jazzaf, Louis DeSantis, Peter A Netland
Investigative Ophthalmology & Visual Science|December 31, 2005
Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administrationGábor Holló, Jess T Whitson, Robert Faulkner, et al.
Survey of Ophthalmology|September 3, 2002
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonistMark R Hellberg, Marsha A McLaughlin, Naj A Sharif, et al.
Pageof 1